Overcoming Immune Blockade in Non-Small Cell Lung Cancer
Progress and challenges are on the way to a blood-based assay for PD-L1.
Read MorePosted by Elaine Sanchez Wilson | Apr 19, 2018 | Disease States |
Progress and challenges are on the way to a blood-based assay for PD-L1.
Read MorePosted by Elaine Sanchez Wilson | Apr 12, 2018 | Prostate |
Updated guidelines include new language supporting the use of Prolaris, from Myriad Genetics, as standard of care in treatment decisionmaking for patients with low-risk and favorable-intermediate-risk prostate cancer.
Read MorePosted by Elaine Sanchez Wilson | Apr 9, 2018 | Prostate, Research |
The United Kingdom’s 100,000 Genomes Project, led by Genomics England and Illumina, has reached a major milestone by sequencing 50,000 genomes.
Read MorePosted by Elaine Sanchez Wilson | Apr 9, 2018 | Breast, Controls, Prostate |
The test from 23andMe is the first to report on three specific BRCA1/BRCA2 breast cancer gene mutations that are most common in people of Ashkenazi Jewish descent.
Read MorePosted by Elaine Sanchez Wilson | Apr 6, 2018 | Culture Media |
Leveraging existing lab data can improve laboratory performance and profitability.
Read More